CLINICAL_TRIALS
trial_result
· 2023-05-06
Clinical Trial Update: Enzalutamide + External Beam Rt For Prostate [Phase 2]
Summary
Phase 2 trial evaluating enzalutamide combined with external beam radiotherapy in intermediate-risk prostate cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Intermediate Risk Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-05-06